van Leeuwen R - Search Results

1

Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis.

Koot M, van Leeuwen R, de Goede RE, Keet IP, Danner S, Eeftinck Schattenkerk JK, Reiss P, Tersmette M, Lange JM, Schuitemaker H. Koot M, et al. Among authors: van leeuwen r. J Infect Dis. 1999 Jan;179(1):254-8. doi: 10.1086/314539. J Infect Dis. 1999. PMID: 9841850

2

Additive or sequential nucleoside analogue therapy compared with continued zidovudine monotherapy in human immunodeficiency virus-infected patients with advanced disease does not prolong survival: an observational study.

van Leeuwen R, Bonsel GJ, Reiss P, Danner SA, Lange JM. van Leeuwen R, et al. J Infect Dis. 1997 Jun;175(6):1344-51. doi: 10.1086/516466. J Infect Dis. 1997. PMID: 9180173 Clinical Trial.

3

Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.

van't Wout AB, Ran LJ, de Jong MD, Bakker M, van Leeuwen R, Notermans DW, Loeliger AE, de Wolf F, Danner SA, Reiss P, Boucher CA, Lange JM, Schuitemaker H. van't Wout AB, et al. Among authors: van leeuwen r. J Clin Invest. 1997 Nov 1;100(9):2325-32. doi: 10.1172/JCI119771. J Clin Invest. 1997. PMID: 9410911 Free PMC article.

4

Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents.

Pakker NG, Roos MT, van Leeuwen R, de Jong MD, Koot M, Reiss P, Lange JM, Miedema F, Danner SA, Schellekens PT. Pakker NG, et al. Among authors: van leeuwen r. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 15;16(5):318-26. doi: 10.1097/00042560-199712150-00002. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9420308

5

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.

Wit FW, van Leeuwen R, Weverling GJ, Jurriaans S, Nauta K, Steingrover R, Schuijtemaker J, Eyssen X, Fortuin D, Weeda M, de Wolf F, Reiss P, Danner SA, Lange JM. Wit FW, et al. Among authors: van leeuwen r. J Infect Dis. 1999 Apr;179(4):790-8. doi: 10.1086/314675. J Infect Dis. 1999. PMID: 10068573

6

Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection.

van Leeuwen R, van den Hurk PJ, Jöbsis GJ, van der Wouw PA, Reiss P, Eeftinck Schattenkerk JK, Danner SA, Lange JM. van Leeuwen R, et al. Among authors: van den hurk pj, van der wouw pa. Genitourin Med. 1990 Dec;66(6):418-22. doi: 10.1136/sti.66.6.418. Genitourin Med. 1990. PMID: 2125023 Free PMC article.

7

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

Schuurman R, Nijhuis M, van Leeuwen R, Schipper P, de Jong D, Collis P, Danner SA, Mulder J, Loveday C, Christopherson C, et al. Schuurman R, et al. Among authors: van leeuwen r. J Infect Dis. 1995 Jun;171(6):1411-9. doi: 10.1093/infdis/171.6.1411. J Infect Dis. 1995. PMID: 7539472

8

Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo.

Nijhuis M, Schuurman R, de Jong D, van Leeuwen R, Lange J, Danner S, Keulen W, de Groot T, Boucher CA. Nijhuis M, et al. Among authors: van leeuwen r. J Infect Dis. 1997 Aug;176(2):398-405. doi: 10.1086/514056. J Infect Dis. 1997. PMID: 9237704

9

Efficient inhibition of both syncytium-inducing and non-syncytium-inducing wild-type HIV-1 by lamivudine in vivo.

van 't Wout AB, Ran LJ, Nijhuis M, Tijnagel JM, de Groot T, van Leeuwen R, Boucher CA, Schuitemaker H, Schuurman R. van 't Wout AB, et al. Among authors: van leeuwen r. AIDS. 1998 Jul 9;12(10):1169-76. doi: 10.1097/00002030-199810000-00009. AIDS. 1998. PMID: 9677166

10

Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. Amsterdam Cohort Study.

Maas J, de Roda Husman AM, Brouwer M, Krol A, Coutinho R, Keet I, van Leeuwen R, Schuitemaker H. Maas J, et al. Among authors: van leeuwen r. AIDS. 1998 Dec 3;12(17):2275-80. doi: 10.1097/00002030-199817000-00008. AIDS. 1998. PMID: 9863869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters